Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership8,514 shares
Latest Disclosed Value $ 1,121,635
ProShare Advisors LLC reports 1.43% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 8,514 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $1,121,635 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 8,394 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 1.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,514 120 1.43 1,122 -5.80 0.0017
2026-02-06 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,394 643 8.30 1,191 9.38 0.0021
2025-11-06 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,751 -332 -4.11 1,088 7.19 0.0023
2025-08-07 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,083 -662 -7.57 1,016 4.96 0.0020
2025-05-08 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,745 -787 -8.26 967 -25.67 0.0022
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,532 -11,206 -54.04 1,301 -45.54 0.0030
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,738 9,780 89.25 2,389 58.42 0.0059
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,958 -871 -7.36 1,509 -7.54 0.0040
2024-05-08 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,829 383 3.35 1,631 8.16 0.0043
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,446 -212 -1.82 1,508 15.03 0.0046
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,658 -355 -2.96 1,312 15.81 0.0041
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,013 -429 -3.45 1,133 -10.09 0.0033
2023-05-26 2023-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 12,442 -2,889 -18.84 1,259 -31.24 0.0038
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,442 -2,889 1,259 0.0040
2023-02-02 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,331 535 3.62 1,831 16.48 0.0064
2022-11-07 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,796 534 3.74 1,572 13.01 0.0060
2022-08-01 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,262 -5,034 -26.09 1,391 -23.11 0.0046
2022-05-10 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,296 -5,006 -20.60 1,809 -12.61 0.0039
2022-02-08 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,302 -4,698 -16.20 2,070 -25.57 0.0041
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,000 1,452 5.27 2,781 3.73 0.0078
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,548 5,559 25.28 2,681 25.40 0.0078
2021-05-14 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,989 5,893 36.61 2,138 38.56 0.0067
2021-02-09 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,096 -543 -3.26 1,543 -3.56 0.0057
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,639 302 1.85 1,600 -19.72 0.0074
2020-08-03 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,337 1,978 13.78 1,993 60.34 0.0106
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,359 -7,756 -35.07 1,243 -47.71 0.0089
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,115 -4,827 -17.92 2,377 -2.10 0.0110
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,942 -1,920 -6.65 2,428 -0.37 0.0136
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,862 -5,638 -16.34 2,437 -19.81 0.0146
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 34,500 1,099 3.29 3,039 27.42 0.0182
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 33,401 -6,684 -16.67 2,385 -51.60 0.0167
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,085 165 0.41 4,928 25.65 0.0335
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 39,920 -3,626 -8.33 3,922 8.61 0.0263
2018-05-14 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,546 -6,518 -13.02 3,611 -7.03 0.0235
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 50,064 -1,726 -3.33 3,884 22.37 0.0269
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,790 4,737 10.07 3,174 46.67 0.0292
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,053 -943 -1.96 2,164 4.14 0.0216
2017-05-12 2017-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 47,996 -10,638 -18.14 2,078 -8.42 0.0217
2017-05-08 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 47,996 0 2,078 0.0217
2017-04-25 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,996 2,078
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,634 1,536 2.69 2,269 -21.52 0.0251
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 57,098 -10,048 -14.96 2,891 -5.28 0.0404
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 67,146 -9,021 -11.84 3,052 1.33 0.0393
2016-05-06 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 76,167 -8,552 -10.09 3,012 -37.16 0.0415
2016-02-05 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 84,719 8,191 10.70 4,793 57.41 0.0581
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 76,528 -2,501 -3.16 3,045 -19.32 0.0428
2015-08-11 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 79,029 -5,936 -6.99 3,774 11.86 0.0522
2015-05-08 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 84,965 84,965 0.00 3,374 0.0397
2015-01-30 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -69,256 -100.00 0 -100.00
2014-11-06 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,256 -13,771 -16.59 1,085 -11.93 0.0144
2014-08-08 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 83,027 -42,232 -33.72 1,232 -38.92 0.0160
2014-05-07 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 125,259 90,732 262.79 2,017 526.40 0.0252
2014-02-04 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 34,527 -31,180 -47.45 322 -56.72 0.0048
2013-11-07 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 65,707 9,823 17.58 744 -0.53 0.0177
2013-07-25 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 55,884 55,884 748 0.0147
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.